Celldex Therapeutics: H.C. Wainwright cuts target price to $58 from $64
CLDX•H.C. Wainwright cut its target price for Celldex Therapeutics to $58 from $64.
Related News

Booking Holdings Inc.: Bernstein cuts target price to $172 from $188
BKNG•

Williams-Sonoma target price cut to $245 from $275 by Citigroup
WSM•

Preppers boost UK retail sales, but winter squeeze looms
EWU•

Palladyne AI President and CEO Benjamin G. Wolff acquires $42,250.50 in common shares
PDYN•

Morgan Stanley raises Walmart target price to $135 from $125
WMT•